Log in or Sign up for Free to view tailored content for your specialty!
Gout News
Colchicine price hike led to decreased use for gout, more prescription swaps, ED visits
Following a major price increase in 2010, the use of colchicine for gout declined while rheumatology and emergency department visits for the disease increased, according to data published in JAMA Internal Medicine.
Gout prevalence among Asian Americans doubled between 2011 and 2018
The adjusted prevalence of gout in Asian Americans doubled from 3.3% in 2011-2012 to 6.6% in 2017-2018, numerically exceeding the prevalence in all other racial and ethnic groups, according to data published in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
Glycoprotein acetyl predicts incident, recurrent gout flares
The presence of glycoprotein acetyl predicts first-time and recurring gout flares beyond serum urate, according to data published in Arthritis & Rheumatology.
Biologic DMARDs control ICI-associated inflammatory arthritis quicker than methotrexate
Patients with immune checkpoint inhibitor-associated inflammatory arthritis who receive a biologic DMARD demonstrate quicker arthritis control, but also experience faster cancer progression, vs. methotrexate, according to data.
EULAR launches first patient-reported survey on rheumatic, musculoskeletal disease impacts
EULAR has initiated a survey that will collect data directly from patients on the impact and outcomes of rheumatic and musculoskeletal diseases, according to a statement released during the EULAR 2023 Congress.
EULAR launches RheumaFacts, a ‘unique data repository’ for RMDs across Europe
EULAR has launched RheumaFacts, a novel resource for local and national data regarding rheumatic and musculoskeletal diseases in Europe, according to a presenter at the EULAR 2023 Congress.
Federal Trade Commission sues to block Amgen’s acquisition of Horizon
The Federal Trade Commission has sued to stop Amgen from acquiring Horizon Therapeutics, a potential blockbuster deal that could restrict marketplace competition, according to an FTC press release.
Well-controlled serum urate levels in gout result in lower fracture risk
Patients with gout who achieve and maintain target serum urate levels through urate-lowering therapy demonstrate a reduced risk for fractures, according to data published in Arthritis & Rheumatology.
Trial results show gout therapy of pegloticase, methotrexate maintained eGFR vs. placebo
AUSTIN, Texas —Results from a poster presentation here showed that patients with uncontrolled gout treated with the combined therapy of pegloticase and methotrexate saw a reduction in gout symptoms as well as a stable eGFR.
Venous thromboembolism risk increases within 30 days after gout flare
Patients with gout demonstrate an increased risk for venous thromboembolism during the 30 days following a flare consultation or hospitalization, according to data published in Arthritis & Rheumatology.
-
Headline News
‘Having women at the top’ drives structural change, advances gender equity in GI
January 13, 202510 min read -
Headline News
Do I really have to go to the hospital for my mini stroke?
January 09, 20257 min read -
Headline News
Survey shows radiation oncology in ‘dark place’ as prior authorization burden worsens
January 14, 20255 min read
-
Headline News
‘Having women at the top’ drives structural change, advances gender equity in GI
January 13, 202510 min read -
Headline News
Do I really have to go to the hospital for my mini stroke?
January 09, 20257 min read -
Headline News
Survey shows radiation oncology in ‘dark place’ as prior authorization burden worsens
January 14, 20255 min read